DISSEMINATED INTRAVASCULAR COAGULATION AFTER FACTOR-IX COMPLEX RESOLVED USING PURIFIED FACTOR-IX CONCENTRATE
被引:9
作者:
HADLEY, T
论文数: 0引用数: 0
h-index: 0
机构:
UNIV LOUISVILLE, JAMES GRAHAM BROWN CANC CTR, DEPT MED DIV MED ONCOL HEMATOL, LOUISVILLE, KY 40292 USAUNIV LOUISVILLE, JAMES GRAHAM BROWN CANC CTR, DEPT MED DIV MED ONCOL HEMATOL, LOUISVILLE, KY 40292 USA
HADLEY, T
[1
]
DJULBEGOVIC, B
论文数: 0引用数: 0
h-index: 0
机构:
UNIV LOUISVILLE, JAMES GRAHAM BROWN CANC CTR, DEPT MED DIV MED ONCOL HEMATOL, LOUISVILLE, KY 40292 USAUNIV LOUISVILLE, JAMES GRAHAM BROWN CANC CTR, DEPT MED DIV MED ONCOL HEMATOL, LOUISVILLE, KY 40292 USA
DJULBEGOVIC, B
[1
]
机构:
[1] UNIV LOUISVILLE, JAMES GRAHAM BROWN CANC CTR, DEPT MED DIV MED ONCOL HEMATOL, LOUISVILLE, KY 40292 USA
A patient with hemophilia B developed disseminated intravascular coagulation during treatment with factor IX complex. Factor IX complex was withdrawn, and the patient was treated with monoclonal antibody-purified factor IX. The disseminated intravascular coagulation resolved during treatment with purified factor IX, indicating that purified factor IX does not sustain factor IX complex-induced disseminated intravascular coagulation. This is the first reported case of the use of monoclonal antibody factor IX in a patient with factor IX complex-induced disseminated intravascular coagulation.